182 related articles for article (PubMed ID: 30022604)
21. Comorbidities in patients with gout.
Ichikawa N; Taniguchi A; Urano W; Nakajima A; Yamanaka H
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1045-50. PubMed ID: 22132955
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout.
Lu CC; Wu SK; Chen HY; Chung WS; Lee MC; Yeh CJ
J Rheumatol; 2014 Sep; 41(9):1878-83. PubMed ID: 25086077
[TBL] [Abstract][Full Text] [Related]
23. [The specific features of gout in the elderly].
Tsurko VV; Eliseeva ME; Vorob'ev PA
Ter Arkh; 2014; 86(5):50-5. PubMed ID: 25026802
[TBL] [Abstract][Full Text] [Related]
24. Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities.
Liu S; Sun H; Yang S; Liang N; Gao Y; Qu S; Chen H
J Endocrinol Invest; 2024 May; 47(5):1119-1128. PubMed ID: 37906371
[TBL] [Abstract][Full Text] [Related]
25. Clinical presentation and disease associations of gout: a hospital-based study of 100 patients in Singapore.
Koh WH; Seah A; Chai P
Ann Acad Med Singap; 1998 Jan; 27(1):7-10. PubMed ID: 9588267
[TBL] [Abstract][Full Text] [Related]
26. [Gout in Togolese patients].
Mijiyawa M; Djagnikpo K; Dagbovie K; Agbetra A
Rev Rhum Mal Osteoartic; 1992; 59(7-8):473-7. PubMed ID: 1485137
[TBL] [Abstract][Full Text] [Related]
27. [The clinical characteristics, diagnosis and treatment of patients with gout in China].
Luo H; Fang WG; Zuo XX; Wu R; Li XX; Chen JW; Zhou JG; Yang J; Song H; Duan XJ; Lin XF; Zeng XW; Zeng H
Zhonghua Nei Ke Za Zhi; 2018 Jan; 57(1):27-31. PubMed ID: 29325307
[No Abstract] [Full Text] [Related]
28. Diagnosis and treatment of gout in primary care.
Rakieh C; Conaghan PG
Practitioner; 2011 Dec; 255(1746):17-20, 2-3. PubMed ID: 22272526
[TBL] [Abstract][Full Text] [Related]
29. Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy.
Drivelegka P; Sigurdardottir V; Svärd A; Jacobsson LTH; Dehlin M
Arthritis Res Ther; 2018 Jun; 20(1):108. PubMed ID: 29855389
[TBL] [Abstract][Full Text] [Related]
30. Prospective follow-up of empirically derived Alcohol Dependence subtypes in wave 2 of the National Epidemiologic Survey on Alcohol And Related Conditions (NESARC): recovery status, alcohol use disorders and diagnostic criteria, alcohol consumption behavior, health status, and treatment seeking.
Moss HB; Chen CM; Yi HY
Alcohol Clin Exp Res; 2010 Jun; 34(6):1073-83. PubMed ID: 20374206
[TBL] [Abstract][Full Text] [Related]
31. Associations between alcohol consumption and cardio-metabolic risk factors in young adults.
Du D; Bruno R; Dwyer T; Venn A; Gall S
Eur J Prev Cardiol; 2017 Dec; 24(18):1967-1978. PubMed ID: 28762751
[TBL] [Abstract][Full Text] [Related]
32. Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort study.
Bajpai R; Muller S; Mallen C; Watson L; Richette P; Hider SL; Roddy E
Rheumatology (Oxford); 2021 Dec; 61(1):407-412. PubMed ID: 33744931
[TBL] [Abstract][Full Text] [Related]
33. Comorbidity clusters in people with gout: an observational cohort study with linked medical record review.
Bevis M; Blagojevic-Bucknall M; Mallen C; Hider S; Roddy E
Rheumatology (Oxford); 2018 Aug; 57(8):1358-1363. PubMed ID: 29672754
[TBL] [Abstract][Full Text] [Related]
34. Gout and Metabolic Syndrome: a Tangled Web.
Thottam GE; Krasnokutsky S; Pillinger MH
Curr Rheumatol Rep; 2017 Aug; 19(10):60. PubMed ID: 28844079
[TBL] [Abstract][Full Text] [Related]
35. Gout and rheumatoid arthritis, both to keep in mind in cardiovascular risk management: A primary care retrospective cohort study.
Janssens HJ; Arts PG; Schalk BW; Biermans MC
Joint Bone Spine; 2017 Jan; 84(1):59-64. PubMed ID: 27236260
[TBL] [Abstract][Full Text] [Related]
36. Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis.
Nyberg F; Horne L; Morlock R; Nuevo J; Storgard C; Aiyer L; Hines DM; Ansolabehere X; Chevalier P
Adv Ther; 2016 Jul; 33(7):1180-98. PubMed ID: 27230988
[TBL] [Abstract][Full Text] [Related]
37. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
Nan H; Qiao Q; Dong Y; Gao W; Tang B; Qian R; Tuomilehto J
J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269
[TBL] [Abstract][Full Text] [Related]
38. Comorbidities in patients with crystal diseases and hyperuricemia.
Sattui SE; Singh JA; Gaffo AL
Rheum Dis Clin North Am; 2014 May; 40(2):251-78. PubMed ID: 24703346
[TBL] [Abstract][Full Text] [Related]
39. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
Khanna P; Khanna D; Storgard C; Baumgartner S; Morlock R
Postgrad Med; 2016 Jan; 128(1):34-40. PubMed ID: 26578028
[TBL] [Abstract][Full Text] [Related]
40. Seasonality of gout in Korea: a multicenter study.
Choi HJ; Lee CH; Lee JH; Yoon BY; Kim HA; Suh CH; Choi ST; Song JS; Joo H; Choi SJ; Lee JS; Shin K; Jun JB; Baek HJ
J Korean Med Sci; 2015 Mar; 30(3):240-4. PubMed ID: 25729244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
